Scappaticcio Lorenzo, Caruso Paola, Longo Miriam, Volatile Alessandra, Cirillo Paolo, Di Maio Francesco, Varro Claudia, Amoresano Paglionico Vanda, Wolde Sellasie Sium, Maiorino Maria I, Esposito Katherine, Bellastella Giuseppe
Unit of Endocrinology and Metabolic Diseases, Luigi Vanvitelli University Hospital, Naples, Italy -
Department of Advanced Medical and Surgical Sciences, Luigi Vanvitelli University Hospital, Naples, Italy -
Minerva Surg. 2025 Jun;80(3):274-281. doi: 10.23736/S2724-5691.25.10685-0. Epub 2025 May 22.
Unilateral uptake (i.e., increased radiotracer in one lobe) on a thyroid scan in a patient with Graves' disease (GD) is the distinctive feature of unilateral GD (UGD), representing a rare entity and variant of GD with few documented cases to date. Considering the diagnostic and therapeutical implications of the knowledge of this form of GD, this study was designed to bring more light on the UGD entity within the bilobar thyroid gland.
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed in reporting this systematic review. We developed a search strategy combining terms for Graves or Hyperthyroidism and unilateral systematically and searched PubMed from inception through August 25, 2024. The inclusion criteria were: 1) patients with Graves' hyperthyroidism due to a unilateral involvement in bilobar thyroid gland; 2) articles written in English or any language with an English abstract.
A total of 10 articles met inclusion criteria, in addition to our institutional experience (comprising 27 individual patients in total). All the included studies were case reports/series. Of the 27 patient cases, 20 (74.1%) were female and the mean age of patients was 44.5±10.6 years. 24 patients (88.9%) had overt hyperthyroidism, two (7.4%) subclinical hyperthyroidism, one (3.7%) had initially normal thyroid function. Orbitopathy was present in two cases out of ten (20%). thyrotropin receptor antibodies (TRAb) or thyroid stimulating immunoglobulin (TSI) were positive in 9 cases out of 12 (75%). Right thyroid lobe was involved in 17 cases (63.0%), while the left one in 10 cases (37.0%). Antithyroid drugs ATDs were adopted by 13 patients (68.4%). Four patients (21.1%) underwent surgery, while radioactive iodine (RAI) was performed in two cases. Two cases (15.4%) received a 12-month course of ATD therapy, one of whom recurred. In two out of three cases after hemithyroidectomy hyperthyroidism recurred due to the involvement of the contralateral lobe of the thyroid gland.
Clinicians should be aware of the possibility that GD can present in the bilobar thyroid gland with unilateral gland involvement at scintigraphy. Ultrasound examination is indicated to detect the presence of contralateral thyroid tissue, and to exclude the possibility of a hyperfunctioning nodule or hemiagenesis. When choosing surgery, total thyroidectomy seems to be the appropriate treatment. Further investigation is needed to determine the natural course of UGD and its best management. Future guidelines should consider this form of GD.
格雷夫斯病(GD)患者甲状腺扫描出现单侧摄取(即一叶放射性示踪剂增加)是单侧GD(UGD)的显著特征,这是一种罕见的GD实体和变体,迄今为止记录的病例很少。考虑到这种形式的GD知识对诊断和治疗的影响,本研究旨在更深入地了解双侧甲状腺内的UGD实体。
本系统评价遵循系统评价和Meta分析的首选报告项目(PRISMA)指南。我们制定了一种搜索策略,系统地组合格雷夫斯病或甲状腺功能亢进症以及单侧的术语,并从创刊至2024年8月25日在PubMed上进行搜索。纳入标准为:1)因双侧甲状腺单侧受累导致的格雷夫斯甲状腺功能亢进症患者;2)用英语或有英文摘要的任何语言撰写的文章。
除了我们机构的经验(总共包括27例个体患者)外,共有10篇文章符合纳入标准。所有纳入研究均为病例报告/系列。在27例患者病例中,20例(74.1%)为女性,患者的平均年龄为44.5±10.6岁。24例患者(88.9%)有明显的甲状腺功能亢进症,2例(7.4%)为亚临床甲状腺功能亢进症,1例(3.7%)最初甲状腺功能正常。10例中有2例(20%)存在眼眶病。12例中有9例(75%)促甲状腺素受体抗体(TRAb)或甲状腺刺激免疫球蛋白(TSI)呈阳性。右侧甲状腺叶受累17例(63.0%),左侧受累为10例(37.0%)。13例患者(68.4%)采用抗甲状腺药物(ATD)治疗。4例患者(21.1%)接受了手术,2例进行了放射性碘(RAI)治疗。2例(15.4%)接受了为期12个月的ATD治疗疗程,其中1例复发。在半甲状腺切除术后的3例中有2例由于对侧甲状腺叶受累而复发甲状腺功能亢进症。
临床医生应意识到GD在甲状腺扫描时可能表现为双侧甲状腺单侧受累。建议进行超声检查以检测对侧甲状腺组织的存在,并排除高功能结节或半侧发育不全的可能性。选择手术时,全甲状腺切除术似乎是合适的治疗方法。需要进一步研究以确定UGD的自然病程及其最佳管理方法。未来的指南应考虑这种形式的GD。